Skip to content

GRCE

Grace Therapeutics, Inc.

NASDAQ · Healthcare · Biotechnology · US

$2.11
−0.94%
Ask drillr

Forward multiples

Based on analyst estimates

P/E forward
P/E 2026E
P/E 2027E
P/E 2028E
1.33x
P/S forward
3.93x

Trailing multiples

Trailing twelve months

P/E TTM
PEG TTM
Price / book
0.92x
Price / sales
Price / cash flow
-4.31x

Enterprise value

Enterprise value
$30.6M
EV / sales
EV / EBITDA
-1.19x
EV / EBIT
-1.19x
Market cap
$44.4M

Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026